4//SEC Filing
Matsuda Masaru 4
Accession 0001787306-24-000159
CIK 0001787306other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 7:52 PM ET
Size
7.4 KB
Accession
0001787306-24-000159
Insider Transaction Report
Form 4
Matsuda Masaru
See Remarks
Transactions
- Award
Common Stock
2024-11-18+4,875→ 183,148 total - Sale
Common Stock
2024-11-19$9.68/sh−1,775$17,190→ 181,373 total
Footnotes (3)
- [F1]Represents the vesting of performance stock units ("PSUs") initially granted on January 3, 2022, that were subject to a performance-based vesting condition. The vesting condition was certified as satisfied on November 18, 2022. The PSUs vest 25% per year on each anniversary of the certification date, subject to the Reporting Person's continued service to the Issuer on such vesting date.
- [F2]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable tax withholdings.
- [F3]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $9.22 to $10.09, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001798679
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 7:52 PM ET
- Size
- 7.4 KB